“Professional Ethics and Responsibilities for Business Valuation, Business Ownership Interest, Security, or Intangible Assets in Pharmaceutical Companies” (2022) Journal of Pharmaceutical Negative Results, pp. 1572–1576. doi:10.47750/pnr.2022.13.S09.193.